The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances

NACompletedINTERVENTIONAL
Enrollment

1,525

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
EconomicsFraudDelivery of Health CareHealth ExpendituresCenters for Medicare and Medicaid Services (U.S.)
Interventions
OTHER

Informative letter

The intervention is a letter that describes the Schedule II prescribing activity of the individual in comparison to a peer group of similar prescribers. It highlights the fact that the prescriber's activity is highly unlike her peers.

All Listed Sponsors
collaborator

Centers for Medicare and Medicaid Services

FED

collaborator

General Services Administration (GSA)

FED

lead

Abdul Latif Jameel Poverty Action Lab

OTHER

NCT02345434 - The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances | Biotech Hunter | Biotech Hunter